Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2019-09-07 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Gulf Pharmaceutical Industries Board Meeting Results held on 08/09/2019 at 10:00
Regulatory Filings
2019-09-07 English
وقف التداول موقتا علي أسهم شركة شركة الخليج للصناعات الدوائية
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific regulatory article related to the listing of securities on ADX (Abu Dhabi Securities Exchange) and details the suspension timing coinciding with a board meeting. The document is short (1819 characters) and is an official announcement about trading suspension, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or voting results. It is a regulatory announcement related to trading status. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-09-03 Arabic
Temporary suspension of trading on the shares of Gulf Pharmaceutical Industries
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific regulatory article related to the listing of securities on ADX (Abu Dhabi Securities Exchange) and details the suspension timing coinciding with a board meeting. The document is an official announcement about trading suspension, not a financial report, earnings release, or management discussion. It is regulatory in nature, related to market operations and compliance, and does not contain financial data or detailed report content. Given the short length (1819 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-09-03 English
شركة الخليج للصناعات الدوائية اعلان اجتماع مجلس الإدارة بتاريخ 08/09/2019 الساعة 10:00
Regulatory Filings
2019-09-02 Arabic
Gulf Pharmaceutical Industries Announcement of Board Meeting to be held on 08/09/2019 at 10:00
Regulatory Filings
2019-09-02 English
شركة الخليج للصناعات الدوائية النتائج المالية للفترة المنتهية في 30 يونيو,2019
Regulatory Filings
2019-08-13 Arabic

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.